{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:04:37Z","timestamp":1793765077986,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for Scientific Research of Fujian Medical University","award":["2020QH1024"],"award-info":[{"award-number":["2020QH1024"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J01687"],"award-info":[{"award-number":["2022J01687"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the \u201cEyas Plan\u201d Youth Top-notch Talent Project of Fujian Province","award":["SCYJHBJRC-XN2021"],"award-info":[{"award-number":["SCYJHBJRC-XN2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03710-1","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T10:01:28Z","timestamp":1689933688000},"page":"2753-2764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Head-to-head comparisons of 68Ga-PSMA-11 and 18F-FDG PET\/CT in evaluating patients with upper tract urothelial carcinoma: a prospective pilot study"],"prefix":"10.1007","volume":"55","author":[{"given":"Bo-han","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-ren-shun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-cheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-bing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-7025","authenticated-orcid":false,"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"3","key":"3710_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F Soria","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fern\u00e1ndez MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 35(3):379\u2013387. https:\/\/doi.org\/10.1007\/s00345-016-1928-x","journal-title":"World J Urol"},{"issue":"9","key":"3710_CR2","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","volume":"39","author":"B Alm\u00e5s","year":"2021","unstructured":"Alm\u00e5s B, Halvorsen OJ, Johannesen TB, Beisland C (2021) Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol 39(9):3385\u20133391. https:\/\/doi.org\/10.1007\/s00345-020-03576-3","journal-title":"World J Urol"},{"issue":"5","key":"3710_CR3","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523\u20131525","journal-title":"J Urol"},{"issue":"1","key":"3710_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-012-0877-2","volume":"31","author":"M Cosentino","year":"2013","unstructured":"Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H (2013) Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 31(1):141\u2013145. https:\/\/doi.org\/10.1007\/s00345-012-0877-2","journal-title":"World J Urol"},{"issue":"5","key":"3710_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.eururo.2012.02.042","volume":"61","author":"E Xylinas","year":"2012","unstructured":"Xylinas E, Rink M, Margulis V, Karakiewicz P, Novara G, Shariat SF (2012) Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61(5):1069\u20131070. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.042","journal-title":"Eur Urol"},{"issue":"1","key":"3710_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","volume":"81","author":"R Cathomas","year":"2022","unstructured":"Cathomas R, Lorch A, Bruins HM, Comp\u00e9rat EM, Cowan NC, Efstathiou JA, Fietkau R, Gakis G, Hern\u00e1ndez V, Espin\u00f3s EL, Neuzillet Y, Ribal MJ, Rouanne M, Thalmann GN, van der Heijden AG, Veskim\u00e4e E, Alfred Witjes J, Milowsky MI (2022) The 2021 updated european association of urology guidelines on metastatic urothelial carcinoma. Eur Urol 81(1):95\u2013103. https:\/\/doi.org\/10.1016\/j.eururo.2021.09.026","journal-title":"Eur Urol"},{"issue":"1","key":"3710_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jasc.2020.06.011","volume":"10","author":"ML Zhang","year":"2021","unstructured":"Zhang ML, VandenBussche CJ, Hang JF, Miki Y, McIntire PJ, Peyton S, Vohra P (2021) A review of urinary cytology in the setting of upper tract urothelial carcinoma. J Am Soc Cytopathol 10(1):29\u201335. https:\/\/doi.org\/10.1016\/j.jasc.2020.06.011","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"3710_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","volume":"78","author":"AK Smith","year":"2011","unstructured":"Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC, Jones JS, Campbell SC, Hansel DE (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78(1):82\u201386. https:\/\/doi.org\/10.1016\/j.urology.2011.02.038","journal-title":"Urology"},{"issue":"7","key":"3710_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.urolonc.2011.12.021","volume":"31","author":"J Straub","year":"2013","unstructured":"Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S (2013) Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol 31(7):1166\u20131170. https:\/\/doi.org\/10.1016\/j.urolonc.2011.12.021","journal-title":"Urol Oncol"},{"issue":"3","key":"3710_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrurol.2016.252","volume":"14","author":"J Baard","year":"2017","unstructured":"Baard J, de Bruin DM, Zondervan PJ, Kamphuis G, de la Rosette J, Laguna MP (2017) Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nat Rev Urol 14(3):181\u2013191. https:\/\/doi.org\/10.1038\/nrurol.2016.252","journal-title":"Nat Rev Urol"},{"issue":"9","key":"3710_CR11","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1245\/s10434-013-3000-z","volume":"20","author":"HL Luo","year":"2013","unstructured":"Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT, Chiang PH (2013) Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Oncol 20(9):3121\u20133126. https:\/\/doi.org\/10.1245\/s10434-013-3000-z","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3710_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bju.14053","volume":"121","author":"RQ Guo","year":"2018","unstructured":"Guo RQ, Hong P, Xiong GY, Zhang L, Fang D, Li XS, Zhang K, Zhou LQ (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184\u2013193. https:\/\/doi.org\/10.1111\/bju.14053","journal-title":"BJU Int"},{"issue":"11","key":"3710_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1089\/lap.2018.0015","volume":"28","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zheng S, Li X, Guo S, Wang Y, Zhou F, Liu ZW (2018) Oncologic outcomes of patients undergoing diagnostic ureteroscopy before radical nephroureterectomy for upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 28(11):1316\u20131325. https:\/\/doi.org\/10.1089\/lap.2018.0015","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"1","key":"3710_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL, G\u00fcrses Andersson I, Liedberg F, Mariappan P, Hugh Mostafid A, Pradere B, van Rhijn BWG, Shariat SF, Rai BP, Soria F, Soukup V, Wood RG, Xylinas EN, Masson-Lecomte A, Gontero P (2023) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84(1):49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013","journal-title":"Eur Urol"},{"issue":"3","key":"3710_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00345-016-1859-6","volume":"35","author":"RS Mandalapu","year":"2017","unstructured":"Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O\u2019Brien T, Zlotta A, Matin SF (2017) Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol 35(3):355\u2013365. https:\/\/doi.org\/10.1007\/s00345-016-1859-6","journal-title":"World J Urol"},{"issue":"9","key":"3710_CR16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s00261-017-1443-6","volume":"43","author":"F Zattoni","year":"2018","unstructured":"Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L (2018) Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study. Abdom Radiol (New York) 43(9):2391\u20132399. https:\/\/doi.org\/10.1007\/s00261-017-1443-6","journal-title":"Abdom Radiol (New York)"},{"issue":"3","key":"3710_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/cco.0000000000000518","volume":"31","author":"L Lindenberg","year":"2019","unstructured":"Lindenberg L, Mena E, Choyke PL, Bouchelouche K (2019) PET imaging in renal cancer. Curr Opin Oncol 31(3):216\u2013221. https:\/\/doi.org\/10.1097\/cco.0000000000000518","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"3710_CR18","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1097\/rlu.0000000000002720","volume":"45","author":"HD Zacho","year":"2020","unstructured":"Zacho HD, Pedersen SH, Petersen A, Petersen LJ (2020) 68Ga-PSMA PET\/CT uptake in the ureter caused by ligand expression in urothelial cancer. Clin Nucl Med 45(1):e43\u2013e45. https:\/\/doi.org\/10.1097\/rlu.0000000000002720","journal-title":"Clin Nucl Med"},{"issue":"2","key":"3710_CR19","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1097\/rlu.0000000000003910","volume":"47","author":"S Dang","year":"2022","unstructured":"Dang S, Pereira M, Singh N, Shivdasani D, Roy D, Kesariya J, Rungta R (2022) An unusual case of bilateral ureteric metastasis on PSMA PET-CT scan in carcinoma prostate. Clin Nucl Med 47(2):e203\u2013e204. https:\/\/doi.org\/10.1097\/rlu.0000000000003910","journal-title":"Clin Nucl Med"},{"issue":"5","key":"3710_CR20","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s10147-015-0817-4","volume":"20","author":"S Asai","year":"2015","unstructured":"Asai S, Fukumoto T, Tanji N, Miura N, Miyagawa M, Nishimura K, Yanagihara Y, Shirato A, Miyauchi Y, Kikugawa T, Yokoyama M (2015) Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosis of upper urinary tract urothelial carcinoma. Int J Clin Oncol 20(5):1042\u20131047. https:\/\/doi.org\/10.1007\/s10147-015-0817-4","journal-title":"Int J Clin Oncol"},{"key":"3710_CR21","doi-asserted-by":"publisher","first-page":"615881","DOI":"10.3389\/fonc.2021.615881","volume":"11","author":"ZB Ke","year":"2021","unstructured":"Ke ZB, Lin XD, Chen YH, Lin YZ, Chen SH, Chen SM, Chen Y, Wei Y, Zheng QS, Xue XY, Li XD, Xu N (2021) Role of 18F-FDG-PET\/CT in combination with neutrophil-lymphocyte ratio in the diagnosis of upper urinary tract lesion: can we accurately predict malignant tumor? Front Oncol 11:615881. https:\/\/doi.org\/10.3389\/fonc.2021.615881","journal-title":"Front Oncol"},{"issue":"4","key":"3710_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM (2013) PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40(4):486\u2013495. https:\/\/doi.org\/10.1007\/s00259-012-2298-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3710_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.juro.2017.08.079","volume":"199","author":"S Spatz","year":"2018","unstructured":"Spatz S, Tolkach Y, Jung K, Stephan C, Busch J, Ralla B, Rabien A, Feldmann G, Brossart P, Bundschuh RA, Ahmadzadehfar H, Essler M, Toma M, M\u00fcller SC, Ellinger J, Hauser S, Kristiansen G (2018) Comprehensive evaluation of prostate specific membrane antigen expression in the vasculature of renal tumors: implications for imaging studies and prognostic role. J Urol 199(2):370\u2013377. https:\/\/doi.org\/10.1016\/j.juro.2017.08.079","journal-title":"J Urol"},{"issue":"8","key":"3710_CR24","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ejca.2007.03.007","volume":"43","author":"KA Suhonen","year":"2007","unstructured":"Suhonen KA, Anttila MA, Sillanp\u00e4\u00e4 SM, H\u00e4m\u00e4l\u00e4inen KM, Saarikoski SV, Juhola M, Kosma VM (2007) Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer. Eur J Cancer (Oxford, England: 1990) 43(8):1300\u20131307. https:\/\/doi.org\/10.1016\/j.ejca.2007.03.007","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"1","key":"3710_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"1","key":"3710_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12149-017-1216-x","volume":"32","author":"SP Campbell","year":"2018","unstructured":"Campbell SP, Baras AS, Ball MW, Kates M, Hahn NM, Bivalacqua TJ, Johnson MH, Pomper MG, Allaf ME, Rowe SP, Gorin MA (2018) Low levels of PSMA expression limit the utility of 18F-DCFPyL PET\/CT for imaging urothelial carcinoma. Ann Nucl Med 32(1):69\u201374. https:\/\/doi.org\/10.1007\/s12149-017-1216-x","journal-title":"Ann Nucl Med"},{"issue":"3","key":"3710_CR27","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.18632\/oncotarget.13994","volume":"8","author":"B Heitk\u00f6tter","year":"2017","unstructured":"Heitk\u00f6tter B, Trautmann M, Gr\u00fcnewald I, B\u00f6gemann M, Rahbar K, Gevensleben H, Wardelmann E, Hartmann W, Steinestel K, Huss S (2017) Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST. Oncotarget 8(3):4268\u20134276. https:\/\/doi.org\/10.18632\/oncotarget.13994","journal-title":"Oncotarget"},{"issue":"5","key":"3710_CR28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.euf.2021.07.016","volume":"8","author":"A Tariq","year":"2022","unstructured":"Tariq A, McCart Reed AE, Morton A, Porten S, Vela I, Williams ED, Yaxley JW, Black PC, Roberts MJ (2022) Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications. Eur Urol Focus 8(5):1256\u20131269. https:\/\/doi.org\/10.1016\/j.euf.2021.07.016","journal-title":"Eur Urol Focus"},{"issue":"2","key":"3710_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00259-020-04916-6","volume":"48","author":"J Gao","year":"2021","unstructured":"Gao J, Xu Q, Fu Y, He K, Zhang C, Zhang Q, Shi J, Zhao X, Wang F, Guo H (2021) Comprehensive evaluation of 68Ga-PSMA-11 PET\/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 48(2):561\u2013569. https:\/\/doi.org\/10.1007\/s00259-020-04916-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"3710_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2967\/jnumed.119.234187","volume":"61","author":"J Kuten","year":"2020","unstructured":"Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, Mabjeesh NJ, Yossepowitch O, Mishani E, Even-Sapir E (2020) Head-to-head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET\/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard. J Nucl Med 61(4):527\u2013532. https:\/\/doi.org\/10.2967\/jnumed.119.234187","journal-title":"J Nucl Med"},{"issue":"10","key":"3710_CR31","doi-asserted-by":"publisher","first-page":"e0186280","DOI":"10.1371\/journal.pone.0186280","volume":"12","author":"LH Schmidt","year":"2017","unstructured":"Schmidt LH, Heitk\u00f6tter B, Schulze AB, Schliemann C, Steinestel K, Trautmann M, Marra A, Hillejan L, Mohr M, Evers G, Wardelmann E, Rahbar K, G\u00f6rlich D, Lenz G, Berdel WE, Hartmann W, Wiewrodt R, Huss S (2017) Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer. PloS\u00a0One 12(10):e0186280. https:\/\/doi.org\/10.1371\/journal.pone.0186280","journal-title":"PloS\u00a0One"},{"issue":"2","key":"3710_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00432-019-03113-9","volume":"146","author":"H Schreiber","year":"2020","unstructured":"Schreiber H, H\u00e4nze J, Nimphius W, Verburg FA, Luster M, Hofmann R, Hegele A (2020) Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging. J Cancer Res Clin Oncol 146(2):305\u2013313. https:\/\/doi.org\/10.1007\/s00432-019-03113-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"3710_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.juro.2011.03.121","volume":"186","author":"S Golan","year":"2011","unstructured":"Golan S, Sopov V, Baniel J, Groshar D (2011) Comparison of 11C-choline with 18F-FDG in positron emission tomography\/computerized tomography for staging urothelial carcinoma: a prospective study. J Urol 186(2):436\u2013441. https:\/\/doi.org\/10.1016\/j.juro.2011.03.121","journal-title":"J Urol"},{"issue":"3","key":"3710_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ejrad.2015.12.017","volume":"85","author":"K Kitajima","year":"2016","unstructured":"Kitajima K, Yamamoto S, Fukushima K, Yamakado K, Katsuura T, Igarashi Y, Kawanaka Y, Mouri M, Hirota S (2016) FDG-PET\/CT as a post-treatment restaging tool in urothelial carcinoma: comparison with contrast-enhanced CT. Eur J Radiol 85(3):593\u2013598. https:\/\/doi.org\/10.1016\/j.ejrad.2015.12.017","journal-title":"Eur J Radiol"},{"issue":"1","key":"3710_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/2090598x.2020.1858012","volume":"19","author":"A Aydh","year":"2020","unstructured":"Aydh A, Abufaraj M, Mori K, Quhal F, Pradere B, Motlagh RS, Mostafaei H, Karakiewicz PI, Shariat SF (2020) Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review. Arab J Urol 19(1):59\u201366. https:\/\/doi.org\/10.1080\/2090598x.2020.1858012","journal-title":"Arab J Urol"},{"issue":"1","key":"3710_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.euo.2019.09.004","volume":"3","author":"CS Voskuilen","year":"2020","unstructured":"Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K (2020) Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma. Eur Urol Oncol 3(1):73\u201379. https:\/\/doi.org\/10.1016\/j.euo.2019.09.004","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"3710_CR37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00259-015-3266-4","volume":"43","author":"F Zattoni","year":"2016","unstructured":"Zattoni F, Evangelista L, Guttilla A, Zattoni F (2016) Radiolabelled choline and FDG PET\/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma. Eur J Nucl Med Mol Imaging 43(3):576\u2013577. https:\/\/doi.org\/10.1007\/s00259-015-3266-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3710_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000381269","volume":"96","author":"H Tanaka","year":"2016","unstructured":"Tanaka H, Yoshida S, Komai Y, Sakai Y, Urakami S, Yuasa T, Yamamoto S, Masuda H, Koizumi M, Kohno A, Fukui I, Yonese J, Fujii Y, Kihara K (2016) Clinical value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in upper tract urothelial carcinoma: impact on detection of metastases and patient management. Urol Int 96(1):65\u201372. https:\/\/doi.org\/10.1159\/000381269","journal-title":"Urol Int"},{"issue":"2","key":"3710_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2967\/jnmt.110.081265","volume":"39","author":"L Ceriani","year":"2011","unstructured":"Ceriani L, Suriano S, Ruberto T, Giovanella L (2011) Could different hydration protocols affect the quality of 18F-FDG PET\/CT images? J Nucl Med Technol 39(2):77\u201382. https:\/\/doi.org\/10.2967\/jnmt.110.081265","journal-title":"J Nucl Med Technol"},{"key":"3710_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R (2016) Metabolic phenotype of bladder cancer. Cancer Treat Rev 45:46\u201357. https:\/\/doi.org\/10.1016\/j.ctrv.2016.03.005","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3710_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/blc-150033","volume":"2","author":"PJ Bostr\u00f6m","year":"2016","unstructured":"Bostr\u00f6m PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Margel D, Pintilie M, Kuk C, Milosevic M, Zlotta AR, Bristow RG (2016) Hypoxia marker GLUT-1 (Glucose Transporter 1) is an independent prognostic factor for survival in bladder cancer patients treated with radical cystectomy. Bladder Cancer (Amsterdam, Netherlands) 2(1):101\u2013109. https:\/\/doi.org\/10.3233\/blc-150033","journal-title":"Bladder Cancer (Amsterdam, Netherlands)"},{"issue":"6","key":"3710_CR42","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Sch\u00f6der H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K (2017) 68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 44(6):1014\u20131024. https:\/\/doi.org\/10.1007\/s00259-017-3670-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"3710_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00259-018-3989-0","volume":"45","author":"K Rahbar","year":"2018","unstructured":"Rahbar K, Afshar-Oromieh A, B\u00f6gemann M, Wagner S, Sch\u00e4fers M, Stegger L, Weckesser M (2018) 18F-PSMA-1007 PET\/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics. Eur J Nucl Med Mol Imaging 45(8):1329\u20131334. https:\/\/doi.org\/10.1007\/s00259-018-3989-0","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03710-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T19:08:06Z","timestamp":1696705686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03710-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}